Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Teratoid Tumor, Atypical 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Gliosarcoma 1Glioblastoma 1Choroid Plexus Neoplasms 1Brain Stem Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 14Filgrastim 13Magnetic Resonance Spectroscopy 9Cyclophosphamide 7Carboplatin 7Peripheral Blood Stem Cell Transplantation 6Irinotecan 6Granulocyte Colony-Stimulating Factor 6Etoposide 6X-Rays 5Topotecan 5Thiotepa 5Phantoms, Imaging 5Busulfan 5Biopsy 5Specimen Handling 4Radiotherapy 4Nuclear Medicine Department, Hospital 4Melphalan 4Ifosfamide 4sargramostim 3palbociclib 3olaparib 3etoposide phosphate 3Surgical Procedures, Operative 3Paclitaxel 3ulixertinib 2trioctyl phosphine oxide 2tipifarnib 2tazemetostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × azurin (50-77) × Sarcoma × Clear all
NCT01975116 2017-08-07

p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

Pediatric Brain Tumor Consortium

Phase 1 Completed
18 enrolled
CNSSarcoma

Teratoid Tumor, Atypical, Astrocytoma, Glioblastoma, Medulloblastoma, Oligodendroglioma, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma, Brain Stem Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡